Ascorbyl palmitate/d-α-tocopheryl polyethylene glycol 1000 succinate monoester mixed micelles for prolonged circulation and targeted delivery of compound K for antilung cancer therapy in vitro and in vivo

Youwen Zhang, Deyin Tong, Daobiao Che, Bing Pei, Xiaodong Xia, Gaofeng Yuan, Xin Jin Department of Hospital Pharmacy, The First Hospital of Suqian, Suqian, People’s Republic of China Abstract: The roles of ginsenoside compound K (CK) in inhibiting tumor have been widely recognized in rec...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Zhang Y, Tong D, Che D, Pei B, Xia X, Yuan G, Jin X
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2017
Materias:
Acceso en línea:https://doaj.org/article/1118adf5db074304bda4b74642cea2fb
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:1118adf5db074304bda4b74642cea2fb
record_format dspace
spelling oai:doaj.org-article:1118adf5db074304bda4b74642cea2fb2021-12-02T07:13:42ZAscorbyl palmitate/d-α-tocopheryl polyethylene glycol 1000 succinate monoester mixed micelles for prolonged circulation and targeted delivery of compound K for antilung cancer therapy in vitro and in vivo1178-2013https://doaj.org/article/1118adf5db074304bda4b74642cea2fb2017-01-01T00:00:00Zhttps://www.dovepress.com/ascorbyl-palmitated-alpha-tocopheryl-polyethylene-glycol-1000-succinat-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Youwen Zhang, Deyin Tong, Daobiao Che, Bing Pei, Xiaodong Xia, Gaofeng Yuan, Xin Jin Department of Hospital Pharmacy, The First Hospital of Suqian, Suqian, People’s Republic of China Abstract: The roles of ginsenoside compound K (CK) in inhibiting tumor have been widely recognized in recent years. However, low water solubility and significant P-gp efflux have restricted its application. In this study, CK ascorbyl palmitate (AP)/d-α-tocopheryl polyethylene glycol 1000 succinate monoester (TPGS) mixed micelles were prepared as a delivery system to increase the absorption and targeted antitumor effect of CK. Consequently, the solubility of CK increased from 35.2±4.3 to 1,463.2±153.3 µg/mL. Furthermore, in an in vitro A549 cell model, CK AP/TPGS mixed micelles significantly inhibited cell growth, induced G0/G1 phase cell cycle arrest, induced cell apoptosis, and inhibited cell migration compared to free CK, all indicating that the developed micellar delivery system could increase the antitumor effect of CK in vitro. Both in vitro cellular fluorescence uptake and in vivo near-infrared imaging studies indicated that AP/TPGS mixed micelles can promote cellular uptake and enhance tumor targeting. Moreover, studies in the A549 lung cancer xenograft mouse model showed that CK AP/TPGS mixed micelles are an efficient tumor-targeted drug delivery system with an effective antitumor effect. Western blot analysis further confirmed that the marked antitumor effect in vivo could likely be due to apoptosis promotion and P-gp efflux inhibition. Therefore, these findings suggest that the AP/TPGS mixed micellar delivery system could be an efficient delivery strategy for enhanced tumor targeting and antitumor effects. Keywords: ginsenoside CK, ascorbyl palmitate, TPGS, mixed micelles, anti-tumor therapyZhang YTong DChe DPei BXia XYuan GJin XDove Medical PressarticleGinsenoside CKAscorbyl palmitateTPGSMixed micellesAnti-tumor therapyMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 12, Pp 605-614 (2017)
institution DOAJ
collection DOAJ
language EN
topic Ginsenoside CK
Ascorbyl palmitate
TPGS
Mixed micelles
Anti-tumor therapy
Medicine (General)
R5-920
spellingShingle Ginsenoside CK
Ascorbyl palmitate
TPGS
Mixed micelles
Anti-tumor therapy
Medicine (General)
R5-920
Zhang Y
Tong D
Che D
Pei B
Xia X
Yuan G
Jin X
Ascorbyl palmitate/d-α-tocopheryl polyethylene glycol 1000 succinate monoester mixed micelles for prolonged circulation and targeted delivery of compound K for antilung cancer therapy in vitro and in vivo
description Youwen Zhang, Deyin Tong, Daobiao Che, Bing Pei, Xiaodong Xia, Gaofeng Yuan, Xin Jin Department of Hospital Pharmacy, The First Hospital of Suqian, Suqian, People’s Republic of China Abstract: The roles of ginsenoside compound K (CK) in inhibiting tumor have been widely recognized in recent years. However, low water solubility and significant P-gp efflux have restricted its application. In this study, CK ascorbyl palmitate (AP)/d-α-tocopheryl polyethylene glycol 1000 succinate monoester (TPGS) mixed micelles were prepared as a delivery system to increase the absorption and targeted antitumor effect of CK. Consequently, the solubility of CK increased from 35.2±4.3 to 1,463.2±153.3 µg/mL. Furthermore, in an in vitro A549 cell model, CK AP/TPGS mixed micelles significantly inhibited cell growth, induced G0/G1 phase cell cycle arrest, induced cell apoptosis, and inhibited cell migration compared to free CK, all indicating that the developed micellar delivery system could increase the antitumor effect of CK in vitro. Both in vitro cellular fluorescence uptake and in vivo near-infrared imaging studies indicated that AP/TPGS mixed micelles can promote cellular uptake and enhance tumor targeting. Moreover, studies in the A549 lung cancer xenograft mouse model showed that CK AP/TPGS mixed micelles are an efficient tumor-targeted drug delivery system with an effective antitumor effect. Western blot analysis further confirmed that the marked antitumor effect in vivo could likely be due to apoptosis promotion and P-gp efflux inhibition. Therefore, these findings suggest that the AP/TPGS mixed micellar delivery system could be an efficient delivery strategy for enhanced tumor targeting and antitumor effects. Keywords: ginsenoside CK, ascorbyl palmitate, TPGS, mixed micelles, anti-tumor therapy
format article
author Zhang Y
Tong D
Che D
Pei B
Xia X
Yuan G
Jin X
author_facet Zhang Y
Tong D
Che D
Pei B
Xia X
Yuan G
Jin X
author_sort Zhang Y
title Ascorbyl palmitate/d-α-tocopheryl polyethylene glycol 1000 succinate monoester mixed micelles for prolonged circulation and targeted delivery of compound K for antilung cancer therapy in vitro and in vivo
title_short Ascorbyl palmitate/d-α-tocopheryl polyethylene glycol 1000 succinate monoester mixed micelles for prolonged circulation and targeted delivery of compound K for antilung cancer therapy in vitro and in vivo
title_full Ascorbyl palmitate/d-α-tocopheryl polyethylene glycol 1000 succinate monoester mixed micelles for prolonged circulation and targeted delivery of compound K for antilung cancer therapy in vitro and in vivo
title_fullStr Ascorbyl palmitate/d-α-tocopheryl polyethylene glycol 1000 succinate monoester mixed micelles for prolonged circulation and targeted delivery of compound K for antilung cancer therapy in vitro and in vivo
title_full_unstemmed Ascorbyl palmitate/d-α-tocopheryl polyethylene glycol 1000 succinate monoester mixed micelles for prolonged circulation and targeted delivery of compound K for antilung cancer therapy in vitro and in vivo
title_sort ascorbyl palmitate/d-α-tocopheryl polyethylene glycol 1000 succinate monoester mixed micelles for prolonged circulation and targeted delivery of compound k for antilung cancer therapy in vitro and in vivo
publisher Dove Medical Press
publishDate 2017
url https://doaj.org/article/1118adf5db074304bda4b74642cea2fb
work_keys_str_mv AT zhangy ascorbylpalmitatedalphatocopherylpolyethyleneglycol1000succinatemonoestermixedmicellesforprolongedcirculationandtargeteddeliveryofcompoundkforantilungcancertherapyinvitroandinvivo
AT tongd ascorbylpalmitatedalphatocopherylpolyethyleneglycol1000succinatemonoestermixedmicellesforprolongedcirculationandtargeteddeliveryofcompoundkforantilungcancertherapyinvitroandinvivo
AT ched ascorbylpalmitatedalphatocopherylpolyethyleneglycol1000succinatemonoestermixedmicellesforprolongedcirculationandtargeteddeliveryofcompoundkforantilungcancertherapyinvitroandinvivo
AT peib ascorbylpalmitatedalphatocopherylpolyethyleneglycol1000succinatemonoestermixedmicellesforprolongedcirculationandtargeteddeliveryofcompoundkforantilungcancertherapyinvitroandinvivo
AT xiax ascorbylpalmitatedalphatocopherylpolyethyleneglycol1000succinatemonoestermixedmicellesforprolongedcirculationandtargeteddeliveryofcompoundkforantilungcancertherapyinvitroandinvivo
AT yuang ascorbylpalmitatedalphatocopherylpolyethyleneglycol1000succinatemonoestermixedmicellesforprolongedcirculationandtargeteddeliveryofcompoundkforantilungcancertherapyinvitroandinvivo
AT jinx ascorbylpalmitatedalphatocopherylpolyethyleneglycol1000succinatemonoestermixedmicellesforprolongedcirculationandtargeteddeliveryofcompoundkforantilungcancertherapyinvitroandinvivo
_version_ 1718399501166706688